| Attribute |
Value |
| 52 Week Change |
-0.026848495 |
| Address1 |
345 East Main Street |
| All Time High |
175.1068 |
| All Time Low |
23.980583 |
| Ask |
93.85 |
| Ask Size |
200 |
| Audit Risk |
6 |
| Average Analyst Rating |
2.6 - Hold |
| Average Daily Volume10 Day |
2,320,030 |
| Average Daily Volume3 Month |
2,407,540 |
| Average Volume |
2,407,540 |
| Average Volume10Days |
2,320,030 |
| Beta |
0.461 |
| Bid |
93.68 |
| Bid Size |
100 |
| Board Risk |
8 |
| Book Value |
65.529 |
| City |
Warsaw |
| Compensation As Of Epoch Date |
1,767,139,200 |
| Compensation Risk |
8 |
| Country |
United States |
| Crypto Tradeable |
0 |
| Currency |
USD |
| Current Price |
94.08 |
| Current Ratio |
1.733 |
| Custom Price Alert Confidence |
HIGH |
| Date Short Interest |
1,782,777,600 |
| Day High |
95.48 |
| Day Low |
91.3 |
| Debt To Equity |
59.827 |
| Display Name |
Zimmer Biomet |
| Dividend Date |
1,785,456,000 |
| Dividend Rate |
0.96 |
| Dividend Yield |
1.05 |
| Earnings Call Timestamp End |
1,785,933,000 |
| Earnings Call Timestamp Start |
1,785,933,000 |
| Earnings Growth |
0.341 |
| Earnings Quarterly Growth |
0.308 |
| Earnings Timestamp |
1,785,933,000 |
| Earnings Timestamp End |
1,785,933,000 |
| Earnings Timestamp Start |
1,785,933,000 |
| Ebitda |
2,580,999,936 |
| Ebitda Margins |
0.30693 |
| Enterprise To Ebitda |
9.809 |
| Enterprise To Revenue |
3.011 |
| Enterprise Value |
25,317,650,432 |
| Eps Current Year |
8.47793 |
| Eps Forward |
8.98555 |
| Eps Trailing Twelve Months |
3.86 |
| Esg Populated |
0 |
| Ex Dividend Date |
1,782,345,600 |
| Exchange |
NYQ |
| Exchange Data Delayed By |
0 |
| Exchange Timezone Name |
America/New_York |
| Exchange Timezone Short Name |
EDT |
| Fifty Day Average |
85.918 |
| Fifty Day Average Change |
8.162003 |
| Fifty Day Average Change Percent |
0.094997585 |
| Fifty Two Week Change Percent |
-2.6848495 |
| Fifty Two Week High |
108.29 |
| Fifty Two Week High Change |
-14.209999 |
| Fifty Two Week High Change Percent |
-0.13122171 |
| Fifty Two Week Low |
79.12 |
| Fifty Two Week Low Change |
14.959999 |
| Fifty Two Week Low Change Percent |
0.18907987 |
| Fifty Two Week Range |
79.12 - 108.29 |
| Financial Currency |
USD |
| First Trade Date Milliseconds |
996,067,800,000 |
| Five Year Avg Dividend Yield |
0.85 |
| Float Shares |
192,932,395 |
| Forward Eps |
8.98555 |
| Forward P E |
10.470144 |
| Free Cashflow |
1,044,124,992 |
| Full Exchange Name |
NYSE |
| Full Time Employees |
17,000 |
| Gmt Off Set Milliseconds |
-14,400,000 |
| Governance Epoch Date |
1,782,864,000 |
| Gross Margins |
0.70176005 |
| Gross Profits |
5,901,199,872 |
| Has Pre Post Market Data |
1 |
| Held Percent Insiders |
0.0015199999 |
| Held Percent Institutions |
1.0639399 |
| Implied Shares Outstanding |
193,462,482 |
| Industry |
Medical Devices |
| Industry Disp |
Medical Devices |
| Industry Key |
medical-devices |
| Ir Website |
http://investor.zimmer.com/ |
| Is Earnings Date Estimate |
0 |
| Language |
en-US |
| Last Dividend Date |
1,782,345,600 |
| Last Dividend Value |
0.24 |
| Last Fiscal Year End |
1,767,139,200 |
| Last Split Date |
1,646,092,800 |
| Last Split Factor |
103:100 |
| Long Business Summary |
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, upper extremities, and trauma and CMFT products; sports medicine products for the repair of soft tissue injuries, used in the knee and shoulder; and craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open-heart surgery, trauma, or for deformities of the chest. It offers technology and data, bone cement, and surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, hospitals, healthcare institutions, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. It also offers ROSA Robot, which utilizes robotic technologies to assist a surgeon with implant positioning in total knee arthroplasty or partial knee arthroplasty; and the ZBEdge Platform connects robotic and digital technologies together to collect data before, during and after surgery, that can deliver insights to surgeons to assist in making informed decisions on patient care. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana. |
| Long Name |
Zimmer Biomet Holdings, Inc. |
| Market |
us_market |
| Market Cap |
18,200,950,784 |
| Market State |
POSTPOST |
| Max Age |
86,400 |
| Message Board Id |
finmb_264048 |
| Most Recent Quarter |
1,774,915,200 |
| Net Income To Common |
761,200,000 |
| Next Fiscal Year End |
1,798,675,200 |
| Non Diluted Market Cap |
17,670,863,105 |
| Number Of Analyst Opinions |
21 |
| Open |
91.69 |
| Operating Cashflow |
1,673,699,968 |
| Operating Margins |
0.19687 |
| Overall Risk |
7 |
| Payout Ratio |
0.24870001 |
| Peg Ratio |
0.65 |
| Phone |
574 373 3333 |
| Post Market Change |
-0.09000397 |
| Post Market Change Percent |
-0.09566748 |
| Post Market Price |
93.99 |
| Post Market Time |
1,783,985,779 |
| Previous Close |
91.34 |
| Price Eps Current Year |
11.097049 |
| Price Hint |
2 |
| Price To Book |
1.4357003 |
| Price To Sales Trailing12 Months |
2.1644351 |
| Profit Margins |
0.09052 |
| Quick Ratio |
0.771 |
| Quote Source Name |
Nasdaq Real Time Price |
| Quote Type |
EQUITY |
| Recommendation Key |
hold |
| Recommendation Mean |
2.55556 |
| Region |
US |
| Regular Market Change |
2.74001 |
| Regular Market Change Percent |
2.99979 |
| Regular Market Day High |
95.48 |
| Regular Market Day Low |
91.3 |
| Regular Market Day Range |
91.3 - 95.48 |
| Regular Market Open |
91.69 |
| Regular Market Previous Close |
91.34 |
| Regular Market Price |
94.08 |
| Regular Market Time |
1,783,972,803 |
| Regular Market Volume |
2,724,109 |
| Return On Assets |
0.040960003 |
| Return On Equity |
0.060650002 |
| Revenue Growth |
0.093 |
| Revenue Per Share |
42.68 |
| Sand P52 Week Change |
0.20847368 |
| Sector |
Healthcare |
| Sector Disp |
Healthcare |
| Sector Key |
healthcare |
| Share Holder Rights Risk |
4 |
| Shares Outstanding |
193,462,482 |
| Shares Percent Shares Out |
0.061100002 |
| Shares Short |
11,817,407 |
| Shares Short Previous Month Date |
1,780,012,800 |
| Shares Short Prior Month |
8,717,891 |
| Short Name |
Zimmer Biomet Holdings, Inc. |
| Short Percent Of Float |
0.0802 |
| Short Ratio |
5.22 |
| Source Interval |
15 |
| State |
IN |
| Symbol |
ZBH |
| Target High Price |
130.0 |
| Target Low Price |
83.0 |
| Target Mean Price |
98.04762 |
| Target Median Price |
95.0 |
| Total Cash |
478,500,000 |
| Total Cash Per Share |
2.473 |
| Total Debt |
7,586,999,808 |
| Total Revenue |
8,409,099,776 |
| Tradeable |
0 |
| Trailing Annual Dividend Rate |
0.96 |
| Trailing Annual Dividend Yield |
0.010510182 |
| Trailing Eps |
3.86 |
| Trailing P E |
24.373058 |
| Trailing Peg Ratio |
0.6473 |
| Triggerable |
1 |
| Two Hundred Day Average |
91.56325 |
| Two Hundred Day Average Change |
2.5167542 |
| Two Hundred Day Average Change Percent |
0.02748651 |
| Type Disp |
Equity |
| Volume |
2,724,109 |
| Website |
https://www.zimmerbiomet.com |
| Zip |
46,580 |